Melittin is a Chinese traditional medicine for treating chronic inflammation, immunological diseases and cancers, however, the efficacy of melittin and its mechanism for treating pancreatic ductal adenocarcinoma (PDAC) are still unknown. Here we investigated the anti-cancer activity of melittin and its regulated mechanism(s) in the PDAC models. Melittin was found to suppress tumor growth by promoting cell apoptosis and cell-cycle arrest. Interestingly, the microarray analyses demonstrated that melittin significantly regulated cholesterol biosynthesis pathway during treatment.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pvaARC
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
New analysis shows that some of these amazing flying beasts were far more formidable than we'd ever thought before... -- Read more on...
-
Abstract Background Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is an autosomal dominant inherited neurodegenerative...
-
Do you speak NHS?Oh, yes: you don’t get far in the health service without being able to generate a seamless flow of the right words, if only...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oDLxf6 via IFTTT
-
The government has announced its intention to make sex and relationships education (SRE) statutory in all secondary schools, and to make rel...
-
Abstract Purpose The aim of this study is to evaluate the feasibility of a telehealthcare application for operable lung cancer (OLC) patie...
-
Bristol-Myers Squibb Co Cancer Drug Cost Comes Under Fire In U.K. StockNews.com (blog) NICE noted the evidence that nivolumab can ext...
-
Abstract Background Medical therapy efficacy remains controversial in stricturing Crohn's disease. Cross-sectional imaging, especial...
-
Abstract The applicability of comprehensive two-dimensional gas chromatography (GC×GC) using a single-stage thermal modulator was explored...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o3hqws via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου